Picture of VIVA Biotech Holdings logo

1873 — VIVA Biotech Holdings Share Price

0.000.00%
hk flag iconLast trade - 00:00
HealthcareHighly SpeculativeMid CapSucker Stock

Momentum

Relative Strength (%)
1m+11.54%
3m
6m
1yr
Volume Change (%)
10d/3m
Price vs... (%)
52w High-53.18%
50d MA
200d MA

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Financial Summary

Year End 31st DecUnit201620172018201920202021E2022ECAGR / Avg
Total RevenueCNYm96.49148.25210.03323.06696.962,246.082,894.8963.94%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%n/a+138.1+62.63+123.7n/an/a+31.84n/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Latest News & Insights for 1873

Viva Biotech Holdings (HKG:1873): buy, sell or hold? background image

Viva Biotech Holdings (HKG:1873): buy, sell or hold?

Shares in Viva Biotech Holdings (HKG:1873) are currently trading close to a 52 week high, with the share price up by around 44.8% - to 7.08 - over the past week. On a one-month basis, the Viva Biotech Holdings price has risen by 44.5%....

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202131st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2021 / 2022

Blurred out image of VIVA Biotech Holdings EPS forecast chart

Profile Summary

VIVA Biotech Holdings is a China-based investment holding company. The Company is principally engaged in the provision of the structure-based drug discovery services to biotechnology and pharmaceutical customers worldwide for their pre-clinical stage innovative drug development. The Company’s core technologies include structure-based drug discovery (SBDD) platform, fragment-based drug discovery (FBDD) platform, affinity selection mass spectrometry (ASMS) screening platform and membrane protein targeted drug discovery platform. The Company operates its businesses mainly in the United States, China, Europe and other regions.

Directors

    Last Annual
    December 31st, 2020
    Last Interim
    June 30th, 2021
    Incorporated
    August 27th, 2008
    Public Since
    May 9th, 2019
    No. of Employees
    1,873
    Sector
    Biotechnology & Medical Research
    Industry
    Healthcare
    Exchange
    hk flag iconStock Exchange of Hong Kong Limited
    Shares in Issue
    1,925,644,112
    Blurred out image of a map
    Address
    Shanghai
    Web
    http://website.vivabiotech.wisdomir.com/sc/index.php
    Phone
    Auditors
    Deloitte Touche Tohmatsu

    1873 Share Price Performance

    FAQ

    Or unlock with your email

    Or unlock with your email